Curaleaf Expands Brand Portfolio with Launch of JAMS Cannabis-Infused Edibles

All-New, Flavor-Forward Jellies, Chocolates and Tarts Launching in Florida and Arizona With Additional States To Follow

Curaleaf Holdings, Inc . (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the expansion of its brand portfolio with the launch of JAMS, a flavor-forward cannabis edibles brand designed to meet the needs of new cannabis consumers and those seeking an introduction to edibles. JAMS is now available in Florida and is coming soon to Arizona with additional states to follow in the coming months.

Carefully crafted with an array of flavors, formulas and form factors, JAMS offers a line of cannabis-infused treats in a wide range of dosage options that can take effect in as few as 15 minutes. From microdoseable Tarts to decadent Chocos, JAMS cannabis-infused edibles are expertly formulated utilizing nano and liposomal technologies to ensure consistency and efficacy. The full product lineup includes:

  • Jellies: Perfect for stargazing or couch grazing, these 10mg THC, naturally-flavored and long-lasting treats are offered in Mixed Berry (Indica), Ruby Red Grapefruit (Sativa) and Peach (Hybrid).
  • Fast-Acting Jellies: Providing effects in as few as 15 minutes, these sweet treats are offered in three boldly sour flavors including Sour Watermelon Lime (Indica), Sour Strawberry Lemonade (Sativa) and Sour Green Apple (Hybrid) at 5mg THC each.
  • Chocos: Decadent gourmet chocolate bars with long-lasting effects, available in three nostalgic flavors including White Chocolate Birthday Cake, Milk Chocolate Pretzel, and Dark Chocolate Peppermint at 5mg THC per piece.
  • Tarts: Great for microdosing, these fast-acting, 2.5mg THC tarts are available in Tangerine, Raspberry Lemonade and Strawberry flavors, perfectly pairing sour and sweet.

"We're excited to welcome JAMS to our brand portfolio as part of our continued commitment to developing and expanding access to high-quality cannabis brands and products," said Matt Darin , CEO of Curaleaf. "JAMS speaks to the growing need for innovative, reliable cannabis products that resonate with a wide variety of consumers at all stages of their cannabis journeys. Florida and Arizona remain priority markets for the launch and we look forward to expanding JAMS to additional markets in the very near future."

"JAMS represents the pinnacle of our edibles formulations by combining great flavor with innovative cannabinoid delivery technologies and the highest level of quality and consistency," said Jessie Kater , SVP of Innovation and R&D. "Developed by our team of chemists, biochemists and food scientists, JAMS has undergone rigorous quality, consistency and stability testing to ensure a consistent and reliable experience."

The edibles market has continued to gain popularity throughout the U.S. in the last two years, with gummies and chocolate accounting for an increased share across the category. JAMS' all-star lineup of products is uniquely positioned for cannabis consumers in search of a great-tasting, reliable edibles brand in a variety of form factors to match any occasion.

JAMS is now available at Curaleaf retail locations in Florida and will be launching soon in Arizona . Additional markets including Maryland , Massachusetts , New Jersey , Nevada and New York will follow in the coming months. To learn more about the JAMS, please visit www.hellojams.com.

About Curaleaf Holdings  
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States , Curaleaf currently operates in 19 states with 147 dispensaries and employs nearly 5,500 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com .

FORWARD-LOOKING STATEMENTS  
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the launch of Curaleaf's JAMS brand. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed March 9, 2022 , which is available under the Company's SEDAR profile at https://www.sedar.com , and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

INVESTOR CONTACT  
Curaleaf Holdings, Inc.
Camilo Lyon , Chief Investment Officer
IR@curaleaf.com

MEDIA CONTACT  
Curaleaf Holdings, Inc.
Tracy Brady , SVP Corporate Communications
media@curaleaf.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/curaleaf-expands-brand-portfolio-with-launch-of-jams-cannabis-infused-edibles-301781463.html

SOURCE Curaleaf Holdings, Inc.

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/March2023/27/c5562.html

News Provided by Canada Newswire via QuoteMedia

CURA:CNX,CURLF
The Conversation (0)

Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida

New Hillsborough County location will host grand opening celebration Friday December 13

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Cannabis leaves, US flag.

Cannabis Round-Up: DEA Postpones Rescheduling Hearing, Key Players Share Quarterly Results

November was a busy month for the cannabis industry, with a slew of US-centric developments.

A hearing on cannabis rescheduling was postponed until 2025, although the incoming Trump administration has signaled its intent to follow through on the change despite opposition from some Republican lawmakers.

Meanwhile, several states voted on cannabis measures, and companies reported their latest quarterly results.

Keep reading...Show less
Cannabis plants and a stock chart.

US Cannabis Sales Hit Record in October, Market Set to Reach US$55 Billion by 2030

Cannabis sales in the US reached a record high in October, with retail transactions totaling approximately US$2.8 billion, according to data from LeafLink, a wholesale cannabis platform.

While sales saw a slight 2.1 percent dip compared to September, they were up 6.2 percent year-on-year. Total retail cannabis sales in 2024 are expected to hit US$32.6 billion, representing a 10.8 percent increase over the previous year.

LeafLink attributes much of this growth to new licenses in states such as New York, New Jersey and Ohio.

Keep reading...Show less
Australia flag and cannabis.

Australian Senate Rejects Greens' Bill to Legalise Cannabis

The Australian Greens announced on Wednesday, November 27, that the Legalising Cannabis Bill 2023 was defeated in a 13 to 24 vote, preventing the federal legalisation of cannabis.

“The Labor and Coalition parties joined together to try and hold Australia back in the 1950s by blocking this desperately needed reform,” said Greens Senator for New South Wales David Shoebridge.

Shoebridge said on X that the parties “teamed up” to vote against legalizing cannabis in the Senate, “yet another example of the major parties working together to refuse any sort of progress.”

All 11 Greens Senators voted in favour of the Bill, as did Independent Senators Lidia Thorpe and Tammy Tyrrell.

Keep reading...Show less
Cannabis and Australian money.

Victoria Amends Driving Rules for Medicinal Cannabis Users, Changes Effective in Mid-2025

Both houses of parliament in Victoria, Australia, have successfully passed the Roads and Road Safety Legislation Amendment Bill 2024, Cannabis Council Australia said in a recent newsletter.

The organisation sees this as a “promising development” in the area, calling it a “critical legislative milestone." The bill's passing will allow for judicial discretion when decisions about medicinal cannabis are made.

Magistrates will now have the ability to evaluate individual cases where drivers who hold valid medicinal cannabis prescriptions test positive for THC, but show no signs of impairment.

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Jacksonville, Florida

New Duval County location will host grand opening celebration Friday, December 6 th

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Jacksonville, Florida on Saturday, November 23 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×